期刊文献+

国产阿奇霉素治疗小儿感染性疾病的药物经济学研究 被引量:4

Study of pharmaceutical economics of domestic azithromycin on children with infectious diseases
下载PDF
导出
摘要 目的对国产阿奇霉素与进口阿奇霉素治疗儿童感染性疾病的临床疗效进行成本分析。方法将96例感染性疾病患儿随机分为国产组与进口组,分别应用国产阿奇霉素与进口阿奇霉素,比较两组的治疗效果并进行成本分析。结果国产组有效率为91.7%,进口组有效率为93.8%,两组的治疗有效率比较,差异无统计学意义(P>0.05)。两组不良反应发生例数比较差异无统计学意义(P>0.05)。国产组的检查成本、药物成本、时间成本、总成本均低于进口组,两组比较差异有统计学意义(P<0.05)。国产组的成本效果比为0.24,进口组的成本效果比为0.58。结论国产阿奇霉素与进口阿奇霉素的疗效无差异,但国产阿奇霉素的成本低于进口阿奇霉素,在临床治疗中有更好的性价比。 Objective To study pharmaceutical economics of domestic azithromycin and imported azithromycin in the treatment of children with infectious disease. Methods A total of 96 patients with infectious disease were randomly di- vided into domestic group and imported group. Patients in the domestic group took injection of domestic azithromycin, patients in the imported group accepted injection of imported azithromycin. Compared clinical effect and studied cost analysis of two groups. Results The effective rate in the domestic group was 91.7%, The effective rate in the imported group was 93.8%. Comparative difference between the two groups indicated no statistical significance (P 〉 0.05). Num- ber of adverse reactions of the two groups showed no statistical significance (P 〉 0.05). Check cost, drug cost, time cost, total cost of domestic group were lower than imported group' s,comparative difference between the two groups were sta- tistically significant (P 〈 0.05). C/E of domestic group was 0.24. C/E of imported group was 0.58. Conclusion Efficacy of domestic azithromycin and imported azithromycin show no statistical significance, but domestic azithromycin cost less than the imported azithromycin' s, price-quality ratio of domestic azithromycin is better than imported azithromycin.
作者 王文琴
出处 《中国现代医生》 2013年第19期27-28,31,共3页 China Modern Doctor
关键词 阿奇霉素 感染性疾病 儿童 性价比 Azithromycin Infectious diseases Children Price-quality ratio
  • 相关文献

参考文献9

二级参考文献32

  • 1谢城.阿奇霉素治疗小儿支原体肺炎的疗效分析[J].实用临床医学(江西),2005,6(1):34-35. 被引量:19
  • 2倪江洪,宋小骏,宫剑滨,谢学建,周晓东,张征.国产与进口尼卡地平治疗急症高血压的成本-效果分析[J].中国药师,2006,9(7):632-634. 被引量:1
  • 3王明贵,张婴元.新大环内酯类抗生素——阿齐霉素[J].新药与临床,1997,16(1):38-40. 被引量:199
  • 4Kudoh S,Ucrake T,Hagiwara K,et al.Clinical effect oflow dose long term erythromycin chemotherapy on diffusepanbronchiolitis[J].Nihon Kyobu Shikkan Gakkai Zasshi,l987,25(6):632-642.
  • 5Beigelman A,Gunsten S,Mikols CL,et al.Azithromycinattenuates airway inflammation in a noninfectious mousemodel of allergic asthma[J].Chest,2009,136(2):498-506.
  • 6Nisar N,Guleria R,Kumar S,et al.Mycoplasma pneu-moniae and its role in asthma[J].Postgrad Med J,2007,83(976):100-104.
  • 7Sutherland ER,Brandorff JM,Martin RJ.Atypical bactcalpneumonia and asthma risk[J].J Asthma,2004,41(8):863-868.
  • 8Cazzola M,Salzillo A,Diamare F.PotentiaI role of macro-lide in the treatment of the asthma[J].Monaldi Arch ChestDis,2000,55(3):231-236.
  • 9Harvey RJ,Wallwork BD,Lund VJ.Anti-inflammatoryeffects of macrolides:applications in chronic rhinosinusitis[J].Immunol Allergy Clin North Am,2009,29(4):689-703.
  • 10Meyer M,Huaux F,Gavilanes X,et al.Azithromycinreduces exaggerated cytokine production by M1 alveolarmacrophages in cystic fibrosis[J].Am J Respir Cell MolBiol,2009,41(5):590-602.

共引文献124

同被引文献225

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部